Supply of Additional Pharmaceuticals (Unspecified Drugs)

The contract involves the manufacture and supply of two additional pharmaceuticals, not specifically named, to be delivered under the same regulatory and delivery standards as Propranolol for the Department of Veterans Affairs CMOP locations. It is a subcontract opportunity issued by the National CMOP Office within the Department of Veterans Affairs, focusing on the pharmaceutical manufacturing sector defined by NAICS code 325412. The solicitation was posted on June 11, 2026, with responses due by June 19, 2026. This contract requires adherence to the same stringent quality, regulatory, and distribution requirements already established for Propranolol, ensuring consistency and compliance across all VA consolidated mail outpatient pharmacy (CMOP) operations. While specific details such as the exact drug names, set-aside status, or location information were not provided, the agreement emphasizes supply continuity and regulatory conformity to support the VA’s pharmaceutical needs.